IVERIC bio (OPHT) News Today → The biggest energy story ever? (From Porter & Company) (Ad) Free OPHT Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share HeadlinesStock Analysis All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineGossamer Bio Inc GOSSmorningstar.com - November 5 at 6:12 PMIveric Bio ticks higher as it sees sale to Astellas closing July 11msn.com - June 30 at 12:31 AMIveric Bio falls amid concern about Astellas dealmsn.com - June 29 at 9:29 AMBaird Downgrades IVERIC bio (ISEE)msn.com - May 6 at 8:26 PMApellis Pharmaceuticals: Maintain 'Buy' Following Astellas' $5.9 Billion Acquisition Of Iveric Biomsn.com - May 6 at 8:26 PMIveric Bio (NASDAQ:ISEE) Sold for $5.9Bmsn.com - May 2 at 12:39 AMAstellas to Buy Eye-Drug Maker Iveric Bio for $5.9 Billionmsn.com - May 1 at 2:38 PMAstellas Pharma buys Iveric Bio for $5.9 billionreuters.com - May 1 at 4:38 AMAstellas Pharma to Buy Iveric Bio for $5.9 Billionmsn.com - April 30 at 10:14 PMAstellas Pharma to Buy Iveric Bio for About $5.9Bwsj.com - April 30 at 10:14 PMAstellas Pharma agrees to buy Iveric Bio for $5.9 Billionmsn.com - April 30 at 10:14 PMRobert W. Baird Keeps Their Buy Rating on Iovance Biotherapeutics (IOVA)markets.businessinsider.com - March 3 at 1:42 AMIVERIC Bio Shares Up 14% After Positive Trial Results, 4Q Lossesmarketwatch.com - March 1 at 11:24 AMIveric Bio Shares Rise 16% After FDA Accepts New Drug App for Avacincaptad Pegolmarketwatch.com - February 17 at 8:38 PMDeep Track Capital Now Owns 5.88% of IVERIC bio (ISEE)nasdaq.com - February 16 at 3:27 PMRtw Investments Now Owns 0.60% of IVERIC bio (ISEE)nasdaq.com - February 16 at 3:27 PMISEE IVERIC bio, Inc.seekingalpha.com - September 16 at 8:03 AMWhere IVERIC bio Stands With Analystsmarkets.businessinsider.com - September 7 at 1:06 PMIveric Bio To Announce GATHER2 Trial Data In Septembermarkets.businessinsider.com - August 25 at 5:15 AMWhy Ophthotech (OPHT) Stock Is Surging Todaythestreet.com - January 18 at 6:26 PMIVERIC bio, Inc. 2021 Q2 - Results - Earnings Call Presentationseekingalpha.com - August 9 at 5:37 AM Get IVERIC bio News Delivered to You Automatically Sign up to receive the latest news and ratings for OPHT and its competitors with MarketBeat's FREE daily newsletter. Email Address Trump’s last act as President (Ad)You’ve probably never heard of Executive Order #13972. Signed by President Trump just days before leaving office, it greenlit what could be the most revolutionary technology of the decade… yet it has nothing to do with AI, blockchain, or mRNA vaccines. For the full story, click here. OPHT Media Mentions By Week OPHT Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. OPHT News Sentiment▼0.000.34▲Average Medical News Sentiment OPHT News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. OPHT Articles This Week▼00▲OPHT Articles Average Week Get IVERIC bio News Delivered to You Automatically Sign up to receive the latest news and ratings for OPHT and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: SUPN News Today AVDL News Today EWTX News Today TARO News Today ZLAB News Today HRMY News Today SDGR News Today CPRX News Today SNDX News Today KURA News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:OPHT) was last updated on 5/2/2024 by MarketBeat.com Staff From Our PartnersHave You Seen Elon’s New A.I. Device? (Picture Inside)InvestorPlace😱 This phenomenon is smashing regular market gainsMillPubA.I. is a Tidal Wave - Here’s What to BuyChaikin AnalyticsDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsPOTUS in ‘25 Not Biden/Trump, ButThe Freeport SocietyForget AI, Imperium Is Expected to Grow 320,00% in 3 YearsBanyan Hill PublishingAI “wealth window” is closing June 25thParadigm Press4 coins to be the “Next Bitcoin”True Market Insiders Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding IVERIC bio, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
